Top Stories

SANTA CLARA, Calif., Aug. 27, 2018 /PRNewswire/ -- SI-BONE, Inc., a medical device company that pioneered the minimally invasive surgical ("MIS") treatment of the sacroiliac ("SI") joint with the iFuse Implant System® ("iFuse") announced that iFuse will be added to the List of Refundable Products and Services in France (Liste des Produits et Prestations Remboursables - LPPR), meaning that the French National

NEW YORK, Aug. 23, 2018 /PRNewswire/ -- Centinel Spine, LLC announced today that it has completed initial cases with three different implant portfolios within their FLX™ Platform of Integrated Interbody™ and non-integrated interbody fusion devices.  Centinel Spine is the largest privately-held spine company focused on anterior column reconstruction. FLX devices are 3D-printed, all-titanium implants which feature a combination

SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications, is pleased to announce the successful completion of the first spine fusion surgery using the Valeo C+CSC with Lumen Interbody Fusion Device. The first surgery was performed by Dr.

SAN DIEGO, Aug. 16, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the appointment of Dale Wolf as vice president, Manufacturing, who will oversee the Company's West Carrollton, Ohio manufacturing facility. Mr. Wolf will fill a newly created role emphasizing the importance of the company's

NEW YORK, Aug. 7, 2018 /PRNewswire/ -- Centinel Spine, LLC is pleased to announce that UnitedHealthcare®, the nation's second largest commercial insurer, has issued a positive medical policy for Lumbar Total Disc Replacement (TDR).  This decision affects over 16 million patients covered through UnitedHealthcare, and means that three out of the four largest US commercial providers now

SAN JOSE, Calif., Aug. 7, 2018 /PRNewswire/ -- SI-BONE, Inc., a medical device company that pioneered the minimally invasive surgical (MIS) treatment of the sacroiliac (SI) joint with the iFuse Implant System® ("iFuse") announced that 23 commercial health plans have published exclusive positive coverage policies for the triangular iFuse Implant System.  These exclusive positive coverage policies provide access to